Receive important updates on the latest information on Bioscience & Health Tech in New York City.
NYCEDC July 9, 2015
Life Sciences & Healthcare Bulletin

SBIR Impact NYC - 3rd Cycle Application Deadline, Sept. 9 ›

Every year, SBIR Impact NYC offers specialized SBIR/STTR application assistance to 20 select life sciences and healthcare companies. Assistance includes advanced training workshops and 20 hours of one-on-one expert proposal development support for each company. There are only a few spots left. Apply now!

In The News


Smart Vision Labs Raises $6M ›
New York City based Smart Vision Labs, a winner in NYCEDC’s Pilot Health Tech NYC program, recently raised $6.1M in a round led by TechStars Ventures. The company’s device allows anyone to get an eye exam using a smartphone. Smart Vision Labs’ device is as accurate as autorefractor units that cost more than $10,000. In a pilot with SUNY College of Optometry in New York City, Smart Vision Labs was one of 11 early stage companies in 2014 that won the second annual Pilot Health Tech NYC awards.

Harlem Biospace is Accepting Applications ›
In the coming months, several Harlem Biospace companies members are preparing to graduate out of the space as they grow. This means space will become available for new teams. If you have a venture or a project you believe has strong potential to become one of NYC's top life science startups then we invite you to apply. 

Suneris Launches Vetigel to Expand Operations ›
New York City based Suneris, a participant in NYCEDC’s ELABNYC program, is focused on the manufacture of inventive emergency medical technologies to improve patient care and save lives. In June, the company launched its product, VETIGEL, a plant-based gel that stops severe bleeding in less than twelve seconds. 

ImmuneTarget Raises $300,000 ›
New York City based ImmuneTarget, a participant in NYCEDC’s ELABNYC, recently raised $300K from angel investors. ImmuneTarget is developing novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases. The company’s CEO, Samedy Ouk, stated, “ELAB not only prepared us to deal with fund raising and startup phase but also provided us a lasting network to take us from startup phase to operation phase.” To further support the company’s drug discovery efforts, MSKCC received $570,000 grant from the Leukemia and Lymphoma Society for supporting the drug development of the Rel/NFKB inhibitors with ImmuneTarget.

AdhereTech is Hiring in NYC ›
New York City based AdhereTech, a winner in NYCEDC’s Pilot Health Tech NYC program & one of CIO.com's 10 startups that are disrupting healthcare IT, is actively looking to hire a Director of Business Development. The ideal candidate is someone who: (1) has experience in healthcare sales / biz dev, (2) is based in NYC, (3) has a positive attitude with a great work ethic. Contact careers@adheretech.com for additional information.

Cureatr Raises $13M ›
New York City based Cureatr, creators of a mobile device care coordination solution, received $13M in funding from a syndicate led by Deerfield Partners, Cardinal Partners and Milestone Venture Partners. 

CareDox Raises $900,000 ›
New York City based CareDox is a HIPAA compliant, online health registration and management system for students' medical records and history. The company recently raised $900K for web- based health records for schools.

Early-Stage Life Sciences Funding Initiative ›
Launched earlier this year, the NYC Early-Stage Life Sciences Funding Initiative, a historic $150M co-investment partnership to build new life sciences ventures in New York City, has been gaining great momentum. Flagship Ventures, a partner in the funding initiative, was recently featured in Xconomy discussing their ongoing success as well as their activity in NYC.

GlucoIQ Raises $100k through Thiel Fellowship ›
GlucoIQ, backed by Blueprint Health and Thiel Foundation, helps physicians monitor diabetes patients in real time, and deliver chronic care management programs. Thiel Fellow and Founder, Adithya Ganesh, is currently on leave from Stanford University to build analytics software to help doctors identify and understand trends in diabetes data.

NYC's Growing Life Sciences Eco-System ›
New York City is home to top pharmaceutical companies like Pfizer, Eli Lilly, and Roche and has some of the best centers for basic science on earth. Learn more in this NYCEDC blog post.

Fit4D and Healthfirst Expand Collaboration ›
New York City based Fit4D, an award winner in the Pilot Health Tech NYC program, recently announced that it is expanding its collaboration with Healthfirst to deliver its innovative diabetes platform to Healthfirst’s Spanish and English speaking members with poorly controlled diabetes. This landmark initiative is a critical part of addressing the impact of diabetes within New York City.

Upcoming Events

July 15
NewX2 BioCruise 2015
New York Harbor World Yacht at Pier 81
July 28
NYAS - Leveraging Big Data and Predictive Knowledge to Fight Disease
7 World Trade Center
 
July 29
NYCEDC Entrepreneurship Lab Info Sessions
Einstein Medical College 
September 17
MedTech Metro
Loeb&Loeb 
September 30 
SBIR IMPACT NYC - ABC's of SBIR/STTR Funding
New York University Leslie eLab
October 5-6
16th International Conference on Alzheimer's Drug Discovery
Hyatt Regency Jersey City
October 7
ELAB NYC Info Session
TBD
 

Leasing Opportunities

Who's Hiring in NYC

Learn about additional opportunities on Harlem Biospace's Job Board.

You May Also Like...

Biotech Incubator in Manhattan

Harlem Biospace (Hb), a new biotech incubator and the first of its kind in NYC to offer affordable, shared, wet-lab space for competitively-selected entrants, opened in November 2013. 

Early Stage Life Sciences Funding Initiative
The Early Stage Life Sciences Funding Initiative will inject $150M into ventures engineering cutting-edge medicines, testing and therapies. 

             


Subscribe to the NYC Bioscience Newsletter
Edit your subscription
Unsubscribe lharcum@nycedc.com from this list

Mailing Address
NYCEDC
110 William Street
New York, NY 10038

Add us to your address book